Skip to main content
Premium Trial:

Request an Annual Quote

Prodesse Files for FDA Clearance of Molecular Metapneumovirus Assay

NEW YORK (GenomeWeb News) – Prodesse has filed with the US Food and Drug Administration for 510(k) clearance of its real-time PCR-based Pro hMPV+ Assay for rapid detection of human metapneumovirus.
 
Prodesse said that the assay can provide accurate results in as little as three hours compared to days or weeks for non-molecular methods. hMPV was discovered in 2001 and causes acute respiratory illness. Its prevalence ranges from 6.6 percent to 12 percent annually of patients with symptoms of respiratory infection.
 
The Milwaukee, Wis.-based firm did not say when it expects to receive clearance for the assay.
 
In January, Prodesse received FDA clearance for its ProFlu+ Assay. It currently is developing additional tests for differentiating parainfluenza 1, 2, and 3 viruses and adenovirus.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.